References
- 1. BRADFORD PT, DEVESA SS, ANDERSON WF, TORO JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009; 113:5064-73.
- 2. PETERS MS, THIBODEAU SN, WHITE JW JR, WINKELMANN RK. Mycosis fungoides in children and adolescents. J Am Acad Dermatol. 1990; 22: 1011-18.
- 3. HWANG ST, JANIK JE, JAFFE ES, WILSON WH. Mycosis fungoides and Sezary syndrome. Lancet. 2008; 371:945-57.
- 4. MASSONE C, KODAMA K, KERL H, CERRONI L. Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol. 2005; 29:550-60.
- 5. SANTUCCI M, BIGGERI A, FELLER AC, BURG G. Accuracy, concordance and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma. Arch Dermatol 2000; 136: 497.
- 6. PIMPINELLI N, OLSEN EA, SANTUCCI M, VONDERHEID E, HAEFFNER AC, STEVENS S, et al. Defining early mycosis fungoides. J Am Acad Dermatol 2005; 53:1053-63.
- 7. WILLEMZE R, JAFFE ES, BURG G, CERRONI L, BERTI E, SWERDLOW SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005; 105:3768-3785.
- 8. CERRONI L, FINK-PUCHES R, EL-SHABRAWI-CAELEN L, SOYER HP, LEBOIT PE, KERL H. Solitary skin lesions with histopathologic features of early mycosis fungoides. Am J Dermatopathol. 1999; 21:518-24.
- 9. SANTUCCI M, BIGGERI A, FELLER AC, MASSI D, BURG G. Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol. 2000; 24:40-50.
- 10. SMOLLER BR, BISHOP K, GLUSAC E, KIM YH, HENDRICKSON M. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am. J. Surg. Pathol. 1995; 19:1423-1430.
- 11. STEVENS SR, KE MS, BIROL A, TERHUNE MH, PARRY EJ, ROSS C, et al. A simple clinical scoring system to improve the sensitivity and standardization of the diagnosis of mycosis fungoides type cutaneous T-cell lymphoma: logistic regression of clinical and laboratory data. Br J Dermatol. 2003; 149:513-22.
- 12. RALFKIAER E, CERRONI L, SANDER CA, SMOLLER BR, WILLEMZE R. Mycosis fungoides. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J et al., editors. WHO classification of tumors of the haematopoietic and lymphoid tissues. IARC, Lyon, 2008.
- 13. SANCHEZ JL, ACKERMAN AB. The patch stage of mycosis fungoides: criteria for histologic diagnosis. Am J Dermatopathol. 1979;1:5-26.
- 14. NARAGHI ZS, SEIRAFI H, VALIKHANI M, FARNAGHI F, KAVUSI S, DOWLATI. Assessment of histologic criteria in the diagnosis of mycosis fungoides. Int J Dermatol. 2003;42: 45-52.
- 15. FREEMAN RG. Questions to the editorial board and other authorities [letter]. Am J Dermatopathol. 1986;8:536.
- 16. SUNDRAM UN. Epidermotropic reactions. In: Cualing HD, Kadin ME, Hoang MP, Morgan MB, editors. Cutaneous hematopathology - Approach to the diagnosis of atypical lymphoid-hematopoietic infiltrates in skin. Springer, New York, 2014.
- 17. DALTON SR, CHANDLER WM, ABUZEID M, HOSSLER EW, FERRINGER T, ELSTON DM, et al. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages. Am J Dermatopathol. 2012; 34:586-91.
- 18. CITARELLA L, MASSONE C, KERL H, CERRONI L. Lichen sclerosus with histopathologic features simulating early mycosis fungoides. Am J Dermatopathol. 2003; 25(6):463-5.
- 19. CANDIAGO E, MAROCOLO D, MANGANONI MA, LEALI C, FACCHETTI F. Nonlymphoid intraepidermal mononuclear cell collections (pseudo-Pautrier abscesses). A morphologic and immunophenotypical characterization. Am J Dermatopathol. 2000; 22:1-6.
- 20. MICHIE SA, ABEL EA, HOPPE RT, WARNKE RA, WOOD GS. Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides. Am J Pathol 1990; 137:1447-51.
- 21. WOOD GS, HONG SR, SASAKI DT, ABEL EA, HOPPE RT, WARNKE RA, et al. Leu-8/CD7 antigen expression by CD31 T cells: comparative analysis of skin and blood in mycosis fungoides/ Sezary syndrome relative to normal blood values. J Am Acad Dermatol 1990;22:602-7.
- 22. NUCKOLS JD, SHEA CR, HORENSTEIN MG, BURCHETTE JL, PRIETO VG. Quantitation of intraepidermal T-cell subsets in formalin-fixed, paraffin-embedded tissue helps in the diagnosis of mycosis fungoides. J Cutan Pathol 1999;26:169-75.
- 23. MASSONE C, CRISMAN G, KERL H, CERRONI L. The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality. Br J Dermatol. 2008; 159:881-6.
- 24. BURG G, DUMMER R, HAEFFNER AC, KEMPF W, KADIN M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol 2001;137:949-52.
- 25. WOOD GS, HAEFFNER A, DUMMER R, CROOKS CF. Molecular biology techniques for the diagnosis of cutaneous T-cell lymphoma. Dermatol Clin 1994;12:231-41.
- 26. OLSEN EA, WHITTAKER S, KIM YH, DUVIC M, PRINCE HM, LESSIN SR, et al. Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011; 29:2598-2607.
- 27. LANGERAK AW, GROENEN PJ, BRUGGEMANN M, BELDJORD K, BELLAN C, BONELLO L, et al. EuroClonality/ BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia. 2012; 26:2159-71.
- 28. ZHANG B, BECK AH, TAUBE JM, KOHLER S, SEO K, ZWERNER J, et al. Combined use of PCR-based TCRG and TCRB clonality tests on paraffin-embedded skin tissue in the differential diagnosis of mycosis fungoides and inflammatory dermatoses. J Mol Diagn. 2010; 12:320-7.
- 29. KIKUCHI A, NAKA W, HARADA T, SAKURAOKA K, HARADA R, NISHIKAWA T. Parapsoriasis en plaques: its potential for progression to malignant lymphoma. J Am Acad Dermatol. 1993; 29(3):419-22.
- 30. ACKERMAN AB. If small plaque (digitate) parapsoriasis is a cutaneous T-cell lymphoma, even an ‘abortive’ one, it must be mycosis fungoides! Arch Dermatol. 1996; 132:562-6.
- 31. SIMON M, FLAIG MJ, KIND P, SANDER CA, KAUDEWITZ P. Large plaque parapsoriasis: clinical and genotypic correlations. J Cutan Pathol. 2000; 27:57-60.
- 32. EL-DAROUTI MA, FAWZY MM, HEGAZY RA, ABDEL HAY RM. Hypopigmented parapsoriasis en plaque, a new, overlooked member of the parapsoriasis family: A report of 34 patients and a 7-year experience. J Am Acad Dermatol. 2012; 67:1182-8.
- 33. BURG G, DUMMER R, NESTLE FO, DOEBBELING U, HAEFFNER AC. Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol 1996;132:567-72.
- 34. BURG G, DUMMER R, HAEFFNER AC, KEMPF W, KADIN M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol 2001;137:949-52.
- 35. WOOD GS, REIZNER GT. Small plaque parapsoriasis and large plaque parapsoriasis. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology 3rd ed. Elsevier, 2012.
- 36. WONG HK, MISHRA A, HAKE T, PORCU P. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br J Haematol. 2011; 155:150-66.